ADAM17 and cardiomyopathy: To understand the mechanism of ADAM17 upregulation in doxorubicin-induced cardiomyopathy, bioinformatics tools were used to predict potential transcription factors in the ADAM17 promoter region, including the Animal Transcription factor database (Animal TFDB4), JASPAR, TRANSFAC, and PROMO.